New Delhi, March 31: India's bioeconomy is approaching the $200 billion mark, which is a significant milestone in its development, according to a report released on Tuesday. This is due to strong policy support and a growing pipeline of innovation.The report by Endiya Partners said that the...
bioeconomy
biopharmaceuticals
biotech
clinicaltrials
drug development
gmp infrastructure
government funding
healthcare
india
innovation
pharmaceuticals
policy
r&d
research institutes
startup ecosystem
India Calls for Trust, Reliability and Innovation in Redesigned Global Pharma Supply Chains
Mumbai, February 23: Union Minister J P Nadda on Monday called upon India’s domestic pharmaceutical industry to take a leadership role in the evolving global supply chain by focusing not only on scale but...
artificial intelligence
biopharmaceutical manufacturing
clinicaltrials
disease detection
global supply chain
healthcare
india
innovation
pharmaceutical industry
pharmaceutical quality
predictive diagnostics
quality systems
regulatory affairs
research and development
supply chain resilience